Home > BRISA > Search result
COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 2

Informe diário de evidências COVID-19: busca realizada em 17 de julho de 2020

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde.
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Betacoronavirus/drug effects, Hydroxychloroquine/therapeutic use, Azithromycin/therapeutic use, Lopinavir/therapeutic use, Ritonavir/therapeutic use, Adrenal Cortex Hormones/therapeutic use, Darunavir/therapeutic use, Cobicistat/therapeutic use, Interferon beta-1a/therapeutic use, Ganciclovir/therapeutic use, Oseltamivir/therapeutic use, Meropenem/therapeutic use, Linezolid/therapeutic use, Ribavirin/therapeutic use, Dexamethasone/therapeutic use, Vancomycin/therapeutic use, Cefepime/therapeutic use, Adrenergic beta-1 Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adalimumab/therapeutic use, Etanercept/therapeutic use, Abatacept/therapeutic use, Cohort Studies, Technology Assessment, Biomedical
Fulltext

Perspectivas de tratamiento para COVID-19 (en progreso)

Centro Nacional de Excelencia Tecnológica en Salud.
CONTEXTO: Debido a la contingencia por COVID-19 provocada por el nuevo coronavirus, SARS-CoV-2, en la actualidad hay una intensa investigación de alternativas terapéuticas que sean seguras y eficaces. (Hay registrados 2208 protocolos de estudios en ClinicalTrials.gov1). Con el propósito de conocer el ...
Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Immunoglobulins, Intravenous/therapeutic use, Dexamethasone/therapeutic use, Ivermectin/therapeutic use, Chloroquine/therapeutic use, Hydroxychloroquine/therapeutic use, Lopinavir/therapeutic use, Ritonavir/therapeutic use, Sofosbuvir/therapeutic use, Ribavirin/therapeutic use, Thymosin/therapeutic use, Darunavir/therapeutic use, Cobicistat/therapeutic use, Technology Assessment, Biomedical, Health Evaluation
Fulltext